SureTrader
Interactive Brokers Advertisement
Home > Boards > US Listed > Biotechs > Amarin Corp. PLC ADS (AMRN)

C......."AMARIN was, an is a small company required

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (3) | Next 10 | Previous | Next
ziploc_1 Member Profile
 
Followed By 23
Posts 3,047
Boards Moderated 0
Alias Born 01/02/03
160x600 placeholder
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 10/6/2017 7:23:03 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 10/3/2017 4:26:27 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 10/3/2017 4:26:02 PM
Amarin and HLS Therapeutics Announce Agreement to Commercialize Vascepa® in Canada "GlobeNewswire Inc." - 9/25/2017 6:00:00 AM
Confidential Treatment Order (ct Order) "Edgar (US Regulatory)" - 9/22/2017 1:08:41 PM
Amarin to Present at Cantor Global Healthcare Conference "GlobeNewswire Inc." - 9/20/2017 4:30:00 PM
Amarin Appoints Mark W. Salyer to New Position of Chief Commercial Officer "GlobeNewswire Inc." - 9/13/2017 6:00:00 AM
Amarin to Present at Rodman & Renshaw’s Global Investment Conference "GlobeNewswire Inc." - 9/6/2017 6:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 8/30/2017 4:02:36 PM
Amarin's REDUCE-IT Cardiovascular Outcomes Study of Vascepa to Continue as Planned at Recommendation of Independent Data Moni... "GlobeNewswire Inc." - 8/14/2017 6:00:00 AM
Securities Registration: Employee Benefit Plan (s-8) "Edgar (US Regulatory)" - 8/2/2017 5:06:42 PM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 8/2/2017 6:38:43 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 8/2/2017 6:31:46 AM
Amarin Reports Second Quarter 2017 Financial Results and Provides Update on Operations "GlobeNewswire Inc." - 8/2/2017 5:30:00 AM
Amarin to Report Second Quarter 2017 Results and Host Conference Call on August 2, 2017 "GlobeNewswire Inc." - 7/26/2017 4:30:00 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 7/3/2017 7:22:58 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 7/3/2017 7:22:30 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 7/3/2017 7:22:02 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 7/3/2017 7:20:53 PM
Amarin Corporation plc (Nasdaq: AMRN) to Ring The Nasdaq Stock Market Opening Bell "GlobeNewswire Inc." - 6/12/2017 10:00:00 AM
Vascepa® (Icosapent Ethyl) Showed Reductions in Potentially Atherogenic Lipid Parameters in Statin-Treated Women With Type 2... "GlobeNewswire Inc." - 6/12/2017 7:00:00 AM
Amarin to Present at the Jefferies 2017 Global Healthcare Conference "GlobeNewswire Inc." - 6/1/2017 6:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 5/19/2017 9:07:06 AM
Amarin Announces Expanded Research Relationships and Studies to Help Improve Cardiovascular Care "GlobeNewswire Inc." - 5/18/2017 6:00:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 5/17/2017 5:26:59 PM
ziploc_1   Friday, 10/06/17 06:36:27 AM
Re: concapk post# 115607
Post # of 116645 
C......."AMARIN was, an is a small company required to run a 7000 modified to an 8000 CVOT study costing approx. $250/300 million.
This study called REDUCE-IT would take approx. 4 years to complete and that cost would be mitigated by sales from ANCHOR approval. The FDA knew that they would be harming AMARIN by rescinding the SPA, "THEY DIDN'T CARE".

IMO the FDA was guilty of extortion......They used the Anchor SPA as bait to extort from Amarin a R-IT study BEFORE(i.e. in return for) their considering Anchor). Then ,once the R-T study was established, the FDA pulled the rug out from Amarin at the Adcom, rescinded the Anchor SPA, and left Amarin for dead, hopefully to bury the evidence of their misdeeds.


Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (3) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist